CTRI/2020/07/026645
Recruiting
未知
A Retrospective study on cancer patients attending Ayothidoss pandithar hospital, National Institute of Siddha,Chennai-600047
Ayothidoss Pandithar Hospital0 sites0 target enrollmentTBD
ConditionsHealth Condition 1: C00-D49- Neoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Sponsor
- Ayothidoss Pandithar Hospital
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of confirmed diagnosis by oncologist reports.
- •2\.All cancer patients approaching for Siddha treatment at NIS\-OPD
Exclusion Criteria
- •1\.Patients of not confirmed diagnosis by oncologist reports.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study to observe cancer directed treatment during COVID-19 pandemic situation.CTRI/2020/07/026533ot Applicable
Completed
Not Applicable
Multi-institutional Survey of Patients with Cancer Pain for Gynecologic CancerGynecologic MalignanciesJPRN-UMIN000013875Tottori University School of medicine1,500
Not yet recruiting
Not Applicable
Outcomes following a Multimodal Pain Protocol in Total Knee ArthroplastyTotal knee arthroplasty post operative pain and mobilitySurgery - Other surgeryMusculoskeletal - OsteoarthritisACTRN12612000343808Dr Gerald Yeo100
Completed
Not Applicable
In those undertaking Periacetabular Osteotomy (PAO), does the use of i-Factor bone graft affect bone healing?Developmental Dysplasia of the Hip (DDH)Periacetabular Osteotomy of the Hip (PAO)Musculoskeletal - Other muscular and skeletal disordersSurgery - Surgical techniquesACTRN12621000625875a Trobe Sport and Exercise Medicine Research Centre, La Trobe University295
Completed
Not Applicable
It is the study for analysis of patients of carcinoma esophagus and gastroesophageal junction who have received chemotherapy before.Health Condition 1: null- Patients of ca esophagus and gastroesophageal junction who have received docetaxel, platinum and 5-Fluorouracil as induction therapyCTRI/2014/08/004839ot applicable31